Promoted Content

Promoted Content

X

Digital content for Adare Pharma Solutions

ADARE PHARMA SOLUTIONS

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2020, Corporate Presentation, GMP Certificate 2021, PharmaSynergy February 2021, Executive Interview On Growth & Strategy, THL Partners & Frazier acquires Adare Pharmaceuticals, Adare Aquires Orbis Biosciences

VIDEO(s)

No Video

DIGITAL CONTENT

34 News

34 News

APIs // Active Pharmaceutical Ingredients

12 APIs, 12 USDMF, 3 KDMF, 9 NDC API

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

78 Dossiers, 17 FDA Orange Book, 2 Europe, 59 Listed Dossiers

SERVICES

All Services, Analytical, Drug Product Manufacturing, API & Drug Product Development

All Services
Analytical
- 1 Analytical Method Development
Drug Product Manufacturing
API & Drug Product Development
- 3 Preformulation & Material Science
- 8 Formulation Development

KEY SERVICES

Diffucaps® Customized Release Technology, Microcaps® Taste Masking Technology, AdvaTab® Orally Disintegrating Tablets, Coating Technology, Bioavailability Enhancement Technology, Chewable Tablet Formulation Development, Orodispersible Tablet (ODT) Development, Pediatric Formulation Development, Solubility Enhancement, ORBEXA™ Controlled Release Technology, Unisun® Otic Injectable Technology, Stratum™ Injectable Micro Encapsulation, Optimum® Oral Dose Micro Encapsulation, Diffutab® Customized Release Technology, Minitabs™ MMTS™ Multi Mini Tablet System

Diffucaps® Customized Release Technology
Microcaps® Taste Masking Technology
AdvaTab® Orally Disintegrating Tablets
Coating Technology
Bioavailability Enhancement Technology
Chewable Tablet Formulation Development
Orodispersible Tablet (ODT) Development
Pediatric Formulation Development
Solubility Enhancement
ORBEXA™ Controlled Release Technology
Unisun® Otic Injectable Technology
Stratum™ Injectable Micro Encapsulation
Optimum® Oral Dose Micro Encapsulation
Diffutab® Customized Release Technology
Minitabs™ MMTS™ Multi Mini Tablet System

EXCIPIENTS

1 Regulatory Filings, 1 USDMF

INSPECTIONS & REGISTRATIONS

16 FDA, 15 EDQM, 1 GDUFA

Full View Screen

Full Screen View

Adare Partners with Veeva to Strengthen Quality Operations

Adare Partners with Veeva to Strengthen Quality Operations

CONTRACTPHARMA

11 Jan 2023

Pharma Supply Chain People Moves

Pharma Supply Chain People Moves

Lucy Chard CPHI-ONLINE

01 Dec 2022

Tethis appoints Holger Neecke as the company's Chief Executive Officer

Tethis appoints Holger Neecke as the company's Chief Executive Officer

PRNEWSWIRE

20 Oct 2022

“3 Key Trends” with Ulrike Foley

“3 Key Trends” with Ulrike Foley

CONTRACT PHARMA

12 May 2022

Adare Pharma Solutions: Integrated End-To-End CDMO

Adare Pharma Solutions: Integrated End-To-End CDMO

PHARMATECH

26 Apr 2022

Adare Pharma Solutions Appoints Tom Sellig CEO

Adare Pharma Solutions Appoints Tom Sellig CEO

PRESS RELEASE

07 Jan 2022

The Challenges of Formulating Medicines for Children

The Challenges of Formulating Medicines for Children

PRESS RELEASE

18 Dec 2021

Adare Pharma Solutions Acquires Frontida BioPharm

Adare Pharma Solutions Acquires Frontida BioPharm

PRESS RELEASE

01 Dec 2021

Adare Pharma Solutions Expands Executive Leadership Team

Adare Pharma Solutions Expands Executive Leadership Team

PRNEWSWIRE

27 May 2021

Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome

Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome

PRESS RELEASE

20 Apr 2021

Contact Supplier

View Presentation

Adare POP UP

DCAT Week 2023

Sponsoring

envelop Contact Supplier

Market Place

Home

Menu

Post Enquiry

Market Place

Search